Invitae Corp
NYSE:NVTA
P/FCFE
Price to FCFE
Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.
Market Cap | P/FCFE | ||||
---|---|---|---|---|---|
US |
Invitae Corp
NYSE:NVTA
|
5.4m USD | -0 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
94.9B EUR | 11.8 | |
US |
Cigna Corp
NYSE:CI
|
99.9B USD | 11.5 | ||
US |
CVS Health Corp
NYSE:CVS
|
70B USD | 4.7 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
17B USD | 61.6 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.7B EUR | 4 | |
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.2B USD | 9.6 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
11.9B EUR | 26.6 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.5B EUR | 25.7 | |
US |
DaVita Inc
NYSE:DVA
|
11.9B USD | 19.2 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -29 |
P/FCFE Forward Multiples
Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.